U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C18H25N5O
Molecular Weight 327.424
Optical Activity ( + / - )
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of A-987306

SMILES

[H][C@@]12CCCC[C@]1([H])C3=C(CCC4=C(N=C(N)N=C34)N5CCNCC5)O2

InChI

InChIKey=DJKJVWJQAVGLHJ-WCQYABFASA-N
InChI=1S/C18H25N5O/c19-18-21-16-12(17(22-18)23-9-7-20-8-10-23)5-6-14-15(16)11-3-1-2-4-13(11)24-14/h11,13,20H,1-10H2,(H2,19,21,22)/t11-,13+/m0/s1

HIDE SMILES / InChI

Molecular Formula C18H25N5O
Molecular Weight 327.424
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Description

A-987306 is a new histamine H(4) antagonist. A-987306 is potent in H(4) receptor binding assays (rat H(4), K(i) = 3.4 nM, human H(4) K(i) = 5.8 nM) and demonstrated potent functional antagonism in vitro at human, rat, and mouse H(4) receptors in cell-based FLIPR assays. A-987306 also demonstrated H(4) antagonism in vivo in mice, blocking H(4)-agonist induced scratch responses, and showed anti-inflammatory activity in mice in a peritonitis model. Most interesting was the high potency and efficacy of this compound in blocking pain responses, where it showed an ED(50) of 42 umol/kg (ip) in a rat post-carrageenan thermal hyperalgesia model of inflammatory pain. A-987306 inhibited the scratching response (IC50 = 0.4 umoles/kg, i.p.) with (85%) inhibition seen at 30 umoles/kg, i.p. A-987306 is a potent and selective H4R antagonist with robust antipruritic activity and is a useful tool for further exploration of the role of H4R receptors in vivo.

Originator

Approval Year

Targets

Primary TargetPharmacologyConditionPotency
5.8 nM [Ki]

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown
Palliative
Unknown

PubMed

Sample Use Guides

In Vivo Use Guide
30 umoles/kg, i.p.
Route of Administration: Intraperitoneal
In Vitro Use Guide
A-987306 competitively and potently antagonize rat H4R agonist-mediated responses in [35S]GTPγS binding assays (Kbs = 6 nM) and intracellular calcium mobilization at rat and human receptors (Kbs from 5-10 nM).
Substance Class Chemical
Record UNII
6BVK16R925
Record Status Validated (UNII)
Record Version